Rosiglitazone Facilitates Angiogenic Progenitor Cell Differentiation Toward Endothelial Lineage
Authors:
- Nadia CilibertiNCNadia Ciliberti
- Shu-Hong LiSLShu-Hong Li
- Paul E. SzmitkoPSPaul E. Szmitko
- Richard D. WeiselRWRichard D. Weisel
- Paul W.M. FedakPFPaul W.M. Fedak
- Mohammed Al-OmranMAMohammed Al-Omran
- Wen-Jin CherngWCWen-Jin Cherng
- Ren-Ke LiRLRen-Ke Li
- William L. StanfordWSWilliam L. Stanford
- Subodh VermaSVSubodh Verma
- 23 March 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (11) , 1392-1400
Abstract
Background— Peroxisome proliferator–activated receptor-γ (PPAR-γ) agonists inhibit vascular smooth muscle proliferation and migration and improve endothelial function. It is unknown whether PPAR-γ agonists favorably modulate bone marrow (BM)–derived angiogenic progenitor cells (APCs) to promote endothelial lineage differentiation and early reendothelialization after vascular intervention. Methods and Results— C57/BL6 mice, treated with or without rosiglitazone (8 mg/kg per day), a PPAR-γ agonist, underwent femoral angioplasty. Rosiglitazone treatment attenuated neointimal formation (intima/media ratio: 0.98±0.12 [rosiglitazone] versus 3.1±0.5 [control]; P P P P P Conclusions— Similar to embryonic stem cell–derived progenitors, the adult BM and peripheral blood harbor APCs that are at least bipotential and able to differentiate into endothelial and smooth muscle lineages. The PPAR-γ agonist rosiglitazone promotes the differentiation of these APCs toward the endothelial lineage and attenuates restenosis after angioplasty.Keywords
This publication has 26 references indexed in Scilit:
- Rosiglitazone Reduces the Accelerated Neointima Formation After Arterial Injury in a Mouse Injury Model of Type 2 DiabetesCirculation, 2003
- New Markers of Inflammation and Endothelial Cell ActivationCirculation, 2003
- Endothelial Progenitor CellsCirculation, 2003
- Troglitazone Stimulates Repair of the Endothelium and Inhibits Neointimal Formation in Denuded Rat AortaArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Glitazones and Heart FailureCirculation, 2003
- Combinatorial effects ofFlk1andTal1on vascular and hematopoietic development in the mouseGenes & Development, 2003
- Prostaglandin J2 metabolites inhibit aromatase activity by redox‐sensitive mechanisms: Potential implications for breast cancer therapyInternational Journal of Cancer, 2002
- Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cellsHepatology, 2000
- PPARγ-Ligands Inhibit Migration Mediated by Multiple Chemoattractants in Vascular Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1999
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995